Andreas F. Hoepner
Directorate General For Financial Stability, Financial Services And Capital Markets Union, European Commission
Brussels, BRU, Belgium
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Corporate emissions targets and the neglect of future innovators.
Journal: Science (New York, N.Y.)
Published: April 25, 2024
Socioeconomic and Regional Disparities in Industry-Sponsored Clinical Trials in Multiple Sclerosis.
Journal: JAMA network open
Published: November 29, 2023
Virtues of impact financing: Do financial institutions benefit from considering the environmental impact on financing decisions?
Journal: Journal of environmental management
Published: July 19, 2023
The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reporting System and Our World in Data.
Journal: Frontiers in pharmacology
Published: March 16, 2023
Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System.
Journal: Therapeutic advances in neurological disorders
Published: March 04, 2022
Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA's Adverse Event Reporting System.
Journal: Annals of the rheumatic diseases
Published: April 29, 2021
In the Name of COVID-19: Is the ECB Fuelling the Climate Crisis?
Journal: Environmental & resource economics
Published: July 03, 2020
Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study.
Journal: Therapeutic advances in neurological disorders
Published: October 24, 2018
Vitamin D supplementation differentially affects seasonal multiple sclerosis disease activity.
Journal: Brain and behavior
Published: May 02, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026